NCSCT text logo
  • Champix out of stock 2021

    Champix out of stock

    28th October 2021
    Today the Department of Health and Social Care issued an updated Supply Disruption Alert confirming that there is no resupply date of varenicline from Pfizer and no alternative supplier. See first attachment below.

    14th October 2021
    Pfizer, in agreement with the European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA), have announced that all Champix (varenicline) batches that were found to contain levels of N-nitroso-varenicline above the acceptable level of intake set at both EMA and MHRA level are being recalled at pharmacy and wholesale level. See Champix recall statement from Pfizer dated 14th October below.

    There is no news on when supplies might recommence but it is unlikely to be in the short term.

    25th June 2021
    The second document below is a statement from Pfizer that identifies the presence of nitrosamines in some batches of Champix "above Pfizer’s acceptable level of daily intake (ADI)".

    Some nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time. The statement goes on to say: "For those patients currently prescribed Champix we believe the benefits outweigh the very low potential risks, if any, posed by nitrosamine exposure from varenicline on top of other common sources over a lifetime."

    24th June 2021
    The third document below is a supply disruption alert issued by MHRA and the NHS.

    23rd June 2021
    We have updated the contact information for Pfizer from that contained in the announcement document of the 16th June.

    Updated information: Further questions on switching medication and on supply of Champix can be addressed to Pfizer. The central number is 01304 616 161 and is manned between 9am to 5pm, calls to this number will be routed appropriately. Outside of these hours, enquiries can be submitted via an online form available at:

    16th June 2021
    Pfizer have announced that with immediate effect, there are supply issues with Champix (varenicline). Click on the icon below for the full announcement.